| Patents for C07H 19 - Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro derivatives thereof (20,008) |
|---|
| 01/20/2011 | US20110014196 Drug Transfer into Living Cells |
| 01/20/2011 | CA2767470A1 Non-polar and polar leaving groups |
| 01/19/2011 | CN101948494A Method for extracting cobamamide |
| 01/19/2011 | CN101948493A Industrialized production method for high-purity decitabine |
| 01/19/2011 | CN101948492A Technology for producing cytarabine through chemical synthesis method |
| 01/19/2011 | CN101948439A Extraction method and application to medicine of active alkaloid compounds in cervus nippon temminck |
| 01/19/2011 | CN101157712B Method for separating and purifying cordycepin |
| 01/19/2011 | CN101080417B Amide prodrug of gemcitabine, compositions and use thereof |
| 01/19/2011 | CN101044151B Antiviral 4'-azido-nucleosides |
| 01/18/2011 | CA2511128C Late-pcr |
| 01/13/2011 | WO2011005595A2 2-5a analogs and their methods of use |
| 01/13/2011 | WO2010096201A3 Synthesis of ara-2'-o-methyl-nucleosides, corresponding phosphoramidites and oligonucleotides incorporating novel modifications for biological application in therapeutics, diagnostics, g- tetrad forming oligonucleotides and aptamers |
| 01/13/2011 | US20110009609 2'-hydroxy-protected ribonucleoside derivative and production method thereof |
| 01/13/2011 | US20110009607 Method for preparing dna fragment having sticky end |
| 01/13/2011 | US20110009606 Synthesis of 2',3' - and 3',5' -cyclic phosphate mono-and oligonucleotides |
| 01/13/2011 | US20110009477 Oligonucleotide-based compounds as inhibitors of toll-like receptors |
| 01/13/2011 | US20110009471 Oligonucleotide analogues and methods utilizing the same |
| 01/13/2011 | US20110009356 Novel phosphorus-containing prodrugs |
| 01/13/2011 | US20110009354 5',-substituted adenosynes preparation thereof and use as inhibitors of s-adenosylmethionine decarboxylase |
| 01/13/2011 | CA2767408A1 Chemically modified ligase cofactors, donors and acceptors |
| 01/13/2011 | CA2767253A1 Novel nucleic acid prodrugs and methods of use thereof |
| 01/12/2011 | CN101942000A Nucleotide carrying modifiers and preparation method thereof and method for gene sequencing |
| 01/12/2011 | CN101376667B Intermediate for synthesizing azidothimidine, preparation thereof and use in azidothimidine synthesis |
| 01/12/2011 | CN101250210B Method for synthesizing 5'-chloro-nucleoside |
| 01/11/2011 | US7868163 Isomers of the dinucleotide Ap2A; incubating cADPR or NAD+ with adenine in the presence of ADP-ribosyl cyclase at a neutral pH; enzymatic assay; leukemia or lymphoma |
| 01/11/2011 | US7868162 protonated compounds used as pH stabilizers; activity against resistant strains of bacteria, opportunistic fungi and viruses such as for HIV, HSV,influenza virus; Nu-3 (butyl-phosphate-5'-thymidine-3'-phosphate-butyl); Nu-2 ((4-hydroxybutyl)-phosphate-5'-uridine-2'-methoxy-3'-phosphate-(4-hydroxybutyl)) |
| 01/06/2011 | WO2011003025A1 Synthesis of cyclic diguanosine monophosphate and thiophosphate analogs thereof |
| 01/06/2011 | WO2011003018A2 Halogenated 2-deoxy-lactones, 2'-deoxy--nucleosides, and derivatives thereof |
| 01/06/2011 | WO2011002917A1 Alkoxy-carbonyl-amino-alkynyl-adenosine compounds and derivatives thereof as a2a r agonists |
| 01/06/2011 | WO2011002200A2 Novel guanosine-rich modified oligonucleotides and antiproliferative activity thereof |
| 01/06/2011 | WO2010029574A3 An improved process for the preparation of gemcitabine and its intermediates using novel protecting groups and ion exchange resins |
| 01/06/2011 | US20110003980 Oligo-Aminosaccharide compound |
| 01/06/2011 | US20110003766 Alkoxy-carbonyl-amino-alkynyl-adenosine compounds and derivatives thereof as a2ar agonists |
| 01/06/2011 | US20110003765 Substituted 4--piperidine-1-carboxylic acid esters as a2ar agonists |
| 01/06/2011 | US20110003385 Regulated transcription of targeted genes and other biological events |
| 01/06/2011 | CA2766073A1 Alkoxy-carbonyl-amino-alkynyl-adenosine compounds and derivatives thereof as a2ar agonists |
| 01/05/2011 | EP2270023A1 New polymorphic form of 5-azacytidine |
| 01/05/2011 | EP2270022A1 New polymorphic form of 5-azacytidine |
| 01/05/2011 | EP2268642A1 1' -substituted carba-nucleoside analogs for antiviral treatment |
| 01/05/2011 | EP2268608A2 Stabilized nucleic acid dark quencher-fluorophore probes |
| 01/05/2011 | CN101935702A Nucleotide with removable mark, preparation method thereof of method for gene sequencing |
| 01/05/2011 | CN101935333A Phosphonate analogs of HIV inhibitor compounds |
| 01/04/2011 | US7863438 Stable salt of 3'-phosphoadenosine 5'-phosphosulfate for use as enhanced sulfate donor in pharmaceutical products or health foods |
| 01/04/2011 | US7863431 cyanine dyes, xanthene dyes, porphyrin dyes, coumarin dyes or composite dyes; fluorescent dyes; useful for labeling probes or targets, including nucleic acids and proteins; bioassays |
| 01/04/2011 | US7863253 preventing an ischemic condition, reperfusion injury, a cellular proliferative disorder, a cardiovascular disease, a neurological disorder, a skin disorder, a radiation-induced injury, a wound, or an inflammatory disease; purine ring with nitrile group, furan ring with two hydroxy groups and alkylamide |
| 01/04/2011 | US7863058 solid phase synthesis of oligonucleotides and peptides on silicon chips, multiwell plates, glass beads |
| 01/04/2011 | CA2389544C Compositions and methods for double-targeting virus infections and targeting cancer cells |
| 01/04/2011 | CA2317505C Enzyme catalyzed therapeutic agents |
| 12/30/2010 | US20100331538 Carbocyclic alpha-l-bicyclic nucleic acid analogs |
| 12/30/2010 | US20100331489 Branched water-soluble polymers and their conjugates |
| 12/30/2010 | US20100331274 Antiaging Chirally-Correct Mitoprotectant Amino Acid and Peptide Complexes |
| 12/30/2010 | US20100330608 Molecular transporters based on sugar and its analogues and processes for the preparation thereof |
| 12/30/2010 | US20100330567 Dna markers for management of cancer |
| 12/30/2010 | US20100330563 Medicinal agent for disease associated with epstein-barr virus, and method for screening of the medicinal agent |
| 12/30/2010 | US20100330164 Method of increasing tear production with purinergic receptor agonists |
| 12/29/2010 | WO2010150791A1 Process for production of adenosine tetraphosphate compound |
| 12/29/2010 | WO2010150789A1 Method for synthesizing nucleic acid |
| 12/29/2010 | EP2267165A2 Nucleic acid sequence analysis |
| 12/29/2010 | EP2266996A2 New labelling strategies for the sensitive detection of analytes |
| 12/29/2010 | EP2266994A1 2-propynyl adenosine analgos with modified 5'-ribose groups having A2A agonist activity |
| 12/29/2010 | EP2266965A1 Methods for Isolating Crystalline Form I of 5-Azacytidine |
| 12/29/2010 | EP2265626A2 Nucleotide analogues with quaternary carbon stereogenic centers and methods of use |
| 12/29/2010 | EP2265624A1 Method for preparing nucleotides and related analogues by synthesis on soluble substrate, and biological tools thus prepared |
| 12/29/2010 | EP2084175B1 Hcv nucleoside inhibitor |
| 12/29/2010 | CN101932590A 2',4'-substituted nucleosides as antiviral agents |
| 12/29/2010 | CN101932310A Method for preparing nanoparticles based on functional amphiphilic molecules or macromolecules, and the use thereof |
| 12/29/2010 | CN101928352A Extraction for active ingredients of cordyceps sinensis and application thereof in cigarette filter |
| 12/29/2010 | CN101928317A Extraction of active ingredients of cordyceps sinensis and application of active ingredients to cigarettes |
| 12/29/2010 | CN101928316A Preparation method of high-purity plate-like cordycepin crystal |
| 12/29/2010 | CN101928315A Nucleoside disulfide dinitrogen derivative and preparation method thereof |
| 12/29/2010 | CN101928314A Preparation method for capecitabine |
| 12/29/2010 | CN101928313A New ring-focus phosphate compounds and preparation method thereof |
| 12/28/2010 | USRE42015 N4-acylcytosine-1,3-dioxolane nucleosides for treatment of viral infections |
| 12/28/2010 | US7858774 Synthesis of 5-azacytidine |
| 12/28/2010 | US7858773 Process for preparing substituted benzimidazole compounds |
| 12/28/2010 | US7858660 oral administering a drug mixture of amantadine, rimantadine, and ribavirin or viramidine, and a neuraminidase inhibitor such as oseltamivir, zanamivir, or peramivir; viral disease treatment |
| 12/28/2010 | US7858594 telbivudine; increased solubility, improved bioavailability; hepatitis B |
| 12/28/2010 | US7858320 Method, substances and kits for labeling population of RNA and other substances containing vicinal diols |
| 12/23/2010 | US20100324279 Crystal forms of 2-[2-(4-chlorophenyl)ethoxy]adenosine |
| 12/23/2010 | US20100324278 RNA synthesis-phosphoramidites for synthetic RNA in the reverse direction, and application in convenient introduction of ligands, chromophores and modifications of synthetic RNA at the 3'-end |
| 12/23/2010 | US20100324266 Photocleavable Protecting Groups |
| 12/23/2010 | US20100323980 Improvements to analogous compounds of 6-thioguanosine triphosphate, their use in medical fields and processes for their preparation |
| 12/23/2010 | US20100323420 Regulated apoptosis |
| 12/22/2010 | EP2264172A1 Oligomeric compounds for the modulation of HIF-1alpha expression |
| 12/22/2010 | EP2264044A1 Method for detection of methylcytosine using photoresponsive probe |
| 12/22/2010 | CN101925610A Non-hydrolyzable nucleoside di- or tri-phosphate derivatives and uses thereof |
| 12/22/2010 | CN101921303A Benzisoselenazolone difluorocytidine compound as well as preparation method and application thereof |
| 12/22/2010 | CN101921296A Preparation method of 5'-nucleotide |
| 12/21/2010 | US7855281 cleaving a polynucleotide bound to a substrate via a cleavable thiocarbonate linker to produce a free polynucleotide; release polynucleotide from a solid phase synthesis |
| 12/16/2010 | US20100317838 Cyclic carbonyl monomers functionalized with carbohydrates, polymers derived therefrom, and methods of preparation thereof |
| 12/16/2010 | US20100317612 Method of obtaining of 4-n-furfurylcytosine and/or its derivatives, an anti-aging composition and use of 4-n-furfurylcytosine and/or its derivatives in the manufacture of anti-aging composition |
| 12/16/2010 | US20100317531 Labelled nucleotides |
| 12/16/2010 | US20100317012 Massive parallel method for decoding DNA and RNA |
| 12/16/2010 | US20100316594 Modified 2' and 3' nucleoside prodrugs for treating flaviviridae infections |
| 12/15/2010 | EP2260852A2 Bisphosphonate conjugates and methods of making and using the same |
| 12/15/2010 | EP1411954B1 Modified nucleosides for treatment of viral infections and abnormal cellular proliferation |
| 12/15/2010 | CN101918424A Oncogenic ALL-1 fusion proteins for targeting Drosha-mediated microRNA processing |
| 12/15/2010 | CN101918422A Process for production of ribofuranose derivatives |
| 12/15/2010 | CN101914125A Extraction process of 5'-guanosine acidized reaction liquid |
| 12/15/2010 | CN101914124A Nucleoside phosphonate conjugates as anti HIV agents |